Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;26(4):480-3.

A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy

Dhurjoti Prosad Bhattacharjee  1 , Satrajit Dawn, Sushil Nayak, Pramod Ranjan Roy, Amita Acharya, Ramkrishna Dey
Affiliations

A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy

Dhurjoti Prosad Bhattacharjee et al. J Anaesthesiol Clin Pharmacol. 2010 Oct.

Abstract

Background: Postoperative nausea and vomiting (PONV) is commonly seen after laparoscopic surgery. In this randomized double blind prospective clinical study, we investigated and compared the efficacy of palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy. PATIENTS #ENTITYSTARTX00026;

Methods: Sixty female patients (18-65 yrs of age) undergoing elective laparoscopic cholecystectomy were randomly allocated one of the two groups containing 30 patients each. Group P received palonosetron 75 μg intravenously as a bolus before induction of anaesthesia. Group G received granisetron 2.5 mg intravenously as a bolus before induction.

Results: The incidence of a complete response (no PONV, no rescue medication) during 0-3 hour in the postoperative period was 86.6% with granisetron and 90% with palonosetron, the incidence during 3-24 hour postoperatively was 83.3% with granisetron and 90% with palonosetron. During 24-48 hour, the incidence was 66.6% and 90% respectively (p<0.05). The incidence of adverse effects were statistically insignificant between the groups.

Conclusion: Prophylactic therapy with palonosetron is more effective than granisetron for long term prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy.

Keywords: Granisetron; Laparoscopic surgery; Palonosetron; Postoperative Nausea and Vomiting (PONV).

PubMed Disclaimer

References

    1. Madej T, Simpsom K. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following gynecological surgery. Br J Anaesth. 1986;58:879–83. - PubMed
    1. Jellish WS, Leonetti J P, Sawicki K, et al. Morphine/ ondansetron PCA for postoperative pain, nausea and vomiting after skull base surgery. Otolaryngol Head Neck Surg. 2006;135:175–81. - PubMed
    1. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment and prevention. Anesthesiology. 1992;77:162–84. - PubMed
    1. Blower PR. The role of specific 5-HT3 receptor antagonigm in the control of cytostatic drug-induced emesis. Euro J Cancer. 1990;26(suppl. 1):s8–s11. - PubMed
    1. Newberry NR, Watkins CJ, Sprosen TS, Blackburn TP, Grahame-Smith DG, Leslie RA. BRL 46470 potently antagonizes neural responses activated by 5-HT 3 receptors. Neuropharmacology. 1993;32:729–735. - PubMed